Marshall Wace North America’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$55.4M	Buy	505,691 +487,118	+2,623%	+$50.6M	0.24%	88
2021 Q2	$1.74M	Sell	18,573 -211,437	-92%	-$19.5M	0.01%	846
2021 Q1	$21.2M	Sell	230,010 -447,005	-66%	-$37.7M	0.09%	248
2020 Q4	$49.5M	Buy	677,015 +25,709	+4%	+$1.91M	0.22%	118
2020 Q3	$50.6M	Sell	651,306 -465,441	-42%	-$32M	0.32%	73
2020 Q2	$62.1M	Buy	1,116,747 +230,653	+26%	+$9.87M	0.41%	58
2020 Q1	$26.2M	Buy	886,094 +593,869	+203%	+$20.1M	0.2%	136
2019 Q4	$10.6M	Buy	292,225 +34,526	+13%	+$1.06M	0.05%	277
2019 Q3	$7.02M	Buy	257,699 +87,277	+51%	+$2.26M	0.04%	303
2019 Q2	$4.1M	Sell	170,422 -147,432	-46%	-$3.74M	0.03%	405
2019 Q1	$8.4M	Buy	317,854 +202,785	+176%	+$4.81M	0.06%	231
2018 Q4	$2.25M	Buy	+115,069	New	+$2.26M	0.02%	406
2018 Q2	–	Sell	-189,843	Closed	-$2.7M	–	1885
2018 Q1	$2.7M	Sell	189,843 -940,011	-83%	-$13.9M	0.01%	731
2017 Q4	$16.5M	Buy	+1,129,854	New	+$15.9M	0.09%	263